FDA Grand Rounds - Forensic Proteomics Applied to FDA Regulated Products
U.S. Food and Drug Administration Grand Rounds / National Forensic Chemistry Center presentation · February 5, 2026
Dr. David Skelton of the FDA National Forensic Chemistry Center outlined LC‑MS proteomic techniques used to identify and characterize peptides and proteins in FDA‑regulated products, and presented case studies including identification of semaglutide in an unknown powder, detection of collagen contamination, and a single‑amino‑acid substitution found in a suspect biotherapeutic (date not specified in transcript).
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No related articles available for this source.
